1 July 2017
| Giuseppe Panetti (Prof), Chris Coulson
|
ENTA - Otology
Giuseppe Panetti is a renowned otologist and one of the forerunners of endoscopic ear surgery. One of his major contributions to ENT has been through designing bespoke equipment to assist in some of the challenges of operating endoscopically. In this...
1 July 2017
| Giuseppe Panetti (Prof), Chris Coulson
|
ENTA - Otology
Giuseppe Panetti is a renowned otologist and one of the forerunners of endoscopic ear surgery. One of his major contributions to ENT has been through designing bespoke equipment to assist in some of the challenges of operating endoscopically. In this...
A nail-biting tiebreaker at the ENT-themed University Challenge. Haseem Raja, ST3 ENT Registrar, University Hospital Coventry & Warwickshire and Daniel Ahari, Academic Foundation Programme Year 1 Doctor at Manchester University NHS Foundation Trust. The North of England Otolaryngology Society and...
Per Cayé-Thomasen is a professor of otology and skull base surgery in Copenhagen. In Milan, he succeeded Cem Meco as the president of the CEORL-HNS. Under his presidency, the confederation has continued to develop its educational activities and encourage professional...
Paediatric ENT is often considered the ‘Cinderella’ subspeciality within otolaryngology. There are efforts in the UK and overseas to redress the balance. Paediatric ENT is a specialised field that addresses the unique needs of children with otolaryngological disorders. Despite its...
Hearing loss and language development Down syndrome (DS) usually arises due to trisomy 21 and is associated with intellectual disability and risks of developmental delays and difficulties, including hearing loss. Hearing loss is common in children with DS [1]. In...
The Ida Institue takes a collaborative approach to developing tools and resources that can be used by clinicians around the world to improve person-centred care. Their Managing Director Lise Lotte Bundesen tells us about their newest project, Inspired by Ida,...
Neuromod Devices, the medical technology company that developed tinnitus treatment device, Lenire, has partnered with an additional 24 new US clinics to address the significant demand for the FDA Approved tinnitus treatment device.
Nature Communications has published the peer-reviewed results of Neuromod Devices’ TENT-A3 (Treatment Evaluation of Neuromodulation for Tinnitus – Stage A3) clinical trial for the first and only FDA-approved bimodal tinnitus treatment device, Lenire.
The year 2020 will be embossed in the archives of history and be remembered like none other before it. The dialogue will largely be centred upon the COVID-19 pandemic, the varied response to it by governments across the world and...